Related Experiment Video

Updated: Jul 20, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Respiratory syncytial virus infection: ten-year follow-up

J T Twiggs, L A Larson, E J O'Connell

    Clinical Pediatrics
    |March 1, 1981
    PubMed

    Insights

    Respiratory syncytial virus (RSV) infection in young children did not increase their risk of developing asthma. This study found no evidence to support RSV as a cause of childhood asthma, challenging previous findings.

    Area of Science:

    • Pediatric respiratory health
    • Infectious disease epidemiology
    • Asthma research

    Background:

    • Previous studies suggest a link between respiratory syncytial virus (RSV) hospitalization and increased childhood asthma incidence.
    • The role of RSV in ambulatory settings and its long-term respiratory consequences remain less understood.
    • Investigating potential causal links between viral infections and chronic respiratory conditions like asthma is crucial.

    Purpose of the Study:

    • To evaluate the long-term respiratory outcomes, specifically asthma development, in children with a history of community-acquired respiratory syncytial virus (RSV) infection.
    • To assess whether RSV infection in a non-hospitalized pediatric population increases the risk for subsequent asthma diagnosis.
    • To compare findings with existing literature and re-evaluate the causative role of RSV in childhood asthma.

    Main Methods:

    • A retrospective follow-up study was conducted on 37 children diagnosed with respiratory syncytial virus (RSV) infection at a pediatric clinic before age 4.
    • Data were collected ten years after the initial diagnosis through chart reviews and parental interviews.
    • The primary outcome assessed was the subsequent diagnosis of asthma in the study cohort.

    Main Results:

    • Over a ten-year follow-up period, asthma was diagnosed in 3 out of 37 children (8%) who had documented respiratory syncytial virus (RSV) infection.
    • This incidence rate did not demonstrate an increased risk for asthma development following RSV infection in this ambulatory pediatric cohort.
    • The findings contrast with some previous studies that reported higher asthma rates after RSV hospitalization.

    Conclusions:

    • The study did not find an increased risk for asthma development after respiratory syncytial virus (RSV) infection in a community-based pediatric population.
    • These results question a direct causative role for RSV in the development of childhood asthma.
    • Further research is needed to clarify the complex relationship between viral infections and asthma etiology.

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

    Published on: January 26, 2019

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    Related Concept Videos

    Common Respiratory Disorders01:31

    Common Respiratory Disorders

    Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
    Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
    Acute Respiratory Failure-I01:21

    Acute Respiratory Failure-I

    Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
    Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    Cytomegalovirus Disease01:27

    Cytomegalovirus Disease

    Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...